electroCore to Announce First Quarter 2021 Financial Results on Thursday, May 6

Rhea-AI Summary

electroCore (NASDAQ: ECOR) announced it will report its Q1 2021 financial results on May 6, 2021, after the market closes. Management will hold a conference call at 4:30 PM ET to discuss the results. The company specializes in bioelectronic medicine aimed at improving patient outcomes through non-invasive vagus nerve stimulation therapy. Current treatment focuses on cluster headaches and migraines. Investors can join the conference via a dedicated webcast link provided in the press release.

Positive

• Scheduled release of Q1 2021 financial results may indicate future growth and transparency.
• Management's conference call allows for direct communication with shareholders.

Negative

• None.

ROCKAWAY, NJ, April 29, 2021 (GLOBE NEWSWIRE) -- electroCore, Inc. (NASDAQ: ECOR), a commercial-stage bioelectronic medicine company, announced that it will report financial results for the first quarter ended March 31, 2021 after the close of the market on Thursday, May 6, 2021. Management will host a conference call and webcast at 4:30pm Eastern Time to discuss the financial results and answer questions.

Thursday, May 6, 2021, 4:30pm Eastern Time
Domestic: 877-269-7756
International: 201-689-7817
Conference ID: 13718262
Webcast: electroCore 1Q21 Business Update Webcast

About electroCore, Inc.
electroCore, Inc. is a commercial-stage bioelectronic medicine company dedicated to improving patient outcomes through its non-invasive vagus nerve stimulation therapy platform, initially focused on the treatment of multiple conditions in neurology. The company's current indications are the preventive treatment of cluster headache and migraine and the acute treatment of migraine and episodic cluster headache.

For more information, visit www.electrocore.com.

FAQ

When will electroCore release its Q1 2021 financial results?

electroCore will report its Q1 2021 financial results on May 6, 2021, after market close.

What time is the electroCore conference call for Q1 2021 results?

The conference call for Q1 2021 results is scheduled for 4:30 PM Eastern Time on May 6, 2021.

What are the current treatment focuses of electroCore?

electroCore currently focuses on treating cluster headaches and migraines through bioelectronic medicine.

How can I access electroCore's Q1 2021 business update?

You can access electroCore's Q1 2021 business update via the webcast link provided in their press release.